What is the 13F Pro Quality Score for PTN?

13F Pro ranks PALATIN TECHNOLOGIES INC (PTN) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View PTN's current score at https://13fpro.ai/research/PTN (free sign-up required for the full ranking).

Where does 13F Pro source PTN data?

All PALATIN TECHNOLOGIES INC fundamentals and ownership data come directly from SEC EDGAR. PALATIN TECHNOLOGIES INC files with the SEC under CIK 911216. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is PTN in?

PALATIN TECHNOLOGIES INC (PTN) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is PTN research updated on 13F Pro?

PTN's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

PALATIN TECHNOLOGIES INC(PTN)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaq

Institutional-grade research for retail investors

SEC EDGAR: CIK 911216 PTN stock profile & AI dashboard →

13F Pro Quality Score

Not in ranked universe

Limited institutional coverage

Quality rankings require at least 50 unique 13-F institutional holders to ensure peer comparisons are meaningful. Only 26 institutional filers currently hold this stock.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

PTN Stock Analysis & AI Quality Score

AI stock analysis and institutional research for PALATIN TECHNOLOGIES INC (PTN), a Healthcare sector company. PTN is not currently included in 13F Pro's AI-ranked quality universe — quality rankings require at least 50 unique 13-f institutional holders to ensure peer comparisons are meaningful. only 26 institutional filers currently hold this stock. Based on the latest XBRL financial filings (Q3 2026), PALATIN TECHNOLOGIES INC reports quarterly revenue of $3.9M, net income of $-1.4M, free cash flow of $-4.5M. Top institutional holders of PTN by reported 13-F value include DRIEHAUS CAPITAL MANAGEMENT, JANUS HENDERSON GROUP PLC, Logos Global Management, based on the most recent SEC filings. PTN trades on the Nasdaq exchange and files with the SEC under CIK 911216. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate PTN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for PALATIN TECHNOLOGIES INC directly from SEC EDGAR.

Revenue

Q3 2026

$3.9M

Net Income

Q3 2026

$-1.4M

Free Cash Flow

Q3 2026

$-4.5M

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

-100.0% YoY

$0.00FY 2025

FY20 $118.0KFY23 $4.9MFY24 $4.5MFY25 $0.00

Net Income

+41.8% YoY

$-17.3MFY 2025

FY20 $-22.4MFY23 $-24.0MFY24 $-29.7MFY25 $-17.3M

Operating Income

+22.4% YoY

$-17.5MFY 2025

FY20 $-23.6MFY23 $-32.5MFY24 $-22.5MFY25 $-17.5M

EPS (Diluted)

+68.2% YoY

$-32.15FY 2025

FY20 $-0.10FY23 —FY24 $-101.16FY25 $-32.15

Total Assets

-69.6% YoY

$3.3MFY 2025

FY20 $85.1MFY23 $17.9MFY24 $10.7MFY25 $3.3M

Total Debt

—FY 2025

FY20 —FY23 —FY24 —FY25 —

Op. Cash Flow

+32.3% YoY

$-21.3MFY 2025

FY20 $41.3MFY23 $-29.3MFY24 $-31.5MFY25 $-21.3M

Metric	FY 2025	FY 2024	FY 2023	FY 2020	FY 2019	FY 2018
Revenue	$0.00 -100.0%	$4.5M -7.5%	$4.9M +4013.7%	$118.0K -99.8%	$60.3M -10.2%	$67.1M
Net Income	$-17.3M +41.8%	$-29.7M -23.7%	$-24.0M -7.2%	$-22.4M -162.7%	$35.8M +44.8%	$24.7M
Operating Income	$-17.5M +22.4%	$-22.5M +30.7%	$-32.5M -37.5%	$-23.6M -166.0%	$35.7M +37.9%	$25.9M
EPS (Diluted)	$-32.15 +68.2%	$-101.16	—	$-0.10 -162.5%	$0.16 +33.3%	$0.12
Total Assets	$3.3M -69.6%	$10.7M -40.1%	$17.9M -78.9%	$85.1M -18.8%	$104.7M +168.4%	$39.0M
Total Debt	—	—	—	—	$332.9K -0.0%	$332.9K
Operating Cash Flow	$-21.3M +32.3%	$-31.5M -7.5%	$-29.3M -170.8%	$41.3M +289.7%	$-21.8M -1379.0%	$1.7M

AI Insight: PTN Financial Trends

Q3 2025 inflection to profitability reversed sharply in Q4 2025, with operating losses returning and revenue collapsing.

• Q3 2025 reached operating breakeven ($5M op income) and net profitability ($5M net income), first profitable quarter in dataset.

• Q4 2025 and Q1 2026 show deterioration: operating losses of $7M and $2M respectively; Q4 2025 revenue fell to $0M.

• Operating cash flow remains persistently negative across all periods ($2M to $7M burn), despite Q3 2025 profit.

⚠ Q3 2025 profitability was a one-quarter anomaly; reversion to losses in Q4 2025–Q1 2026 signals sustainability concerns.

⚠ Equity swung from negative $8M (Q3 2024) to positive $11M (Q4 2025–Q1 2026), but without stable revenue or positive cash flow.

AI Insight: PTN Ratio Trends

Profitability collapsed from Q3 2025's positive margins to substantial losses across all metrics in Q1 2026.

• Operating margin swung from +52.7% in Q3 2025 to -40.3% in Q1 2026, a 93pp reversal.

• Net profit margin fell 89.4pp from +52.9% to -36.5% over same period.

• ROE deteriorated to -54.1% in Q1 2026 from inability to generate earnings on shareholder capital.

⚠ ROIC turned sharply negative at -59.7% in Q1 2026; company destroying invested capital.

⚠ Q3 2025's isolated profitability suggests one-time revenue event; underlying operations unprofitable.

Get alerted when PTN's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for PALATIN TECHNOLOGIES INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of PTN

DRIEHAUS CAPITAL MANAGEMENT LLC
$2.9M166,713 sh
JANUS HENDERSON GROUP PLC
$2.4M140,000 sh
Logos Global Management LP
$2.4M140,000 sh
RA CAPITAL MANAGEMENT, L.P.
$1.2M70,000 sh
PERCEPTIVE ADVISORS LLC
$1.1M61,945 sh
BALYASNY ASSET MANAGEMENT L.P.
$717.2K41,169 sh
SUPERSTRING CAPITAL MANAGEMENT LP
$626.6K35,969 sh
MORGAN STANLEY
$475.1K27,272 sh
VANGUARD CAPITAL MANAGEMENT LLC
$330.6K18,979 sh
GEODE CAPITAL MANAGEMENT, LLC
$322.5K18,502 sh

Fund	Value	Shares
DRIEHAUS CAPITAL MANAGEMENT LLC	$2.9M	166,713
JANUS HENDERSON GROUP PLC	$2.4M	140,000
Logos Global Management LP	$2.4M	140,000
RA CAPITAL MANAGEMENT, L.P.	$1.2M	70,000
PERCEPTIVE ADVISORS LLC	$1.1M	61,945
BALYASNY ASSET MANAGEMENT L.P.	$717.2K	41,169
SUPERSTRING CAPITAL MANAGEMENT LP	$626.6K	35,969
MORGAN STANLEY	$475.1K	27,272
VANGUARD CAPITAL MANAGEMENT LLC	$330.6K	18,979
GEODE CAPITAL MANAGEMENT, LLC	$322.5K	18,502

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put PTN on your watchlist

Track score changes the day PALATIN TECHNOLOGIES INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is PTN a good stock to buy?

13F Pro's AI-powered analysis of PALATIN TECHNOLOGIES INC (PTN) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for PTN are available on the PTN stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own PTN?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling PTN. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of PALATIN TECHNOLOGIES INC's investment landscape.